These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 27766914)
21. N-acetylcysteine blocks serotonin 1B agonist-induced OCD-related behavior in mice. Allen EM; Hughes EF; Anderson CJ; Woehrle NS Behav Neurosci; 2018 Aug; 132(4):258-268. PubMed ID: 29985009 [TBL] [Abstract][Full Text] [Related]
22. Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits. Rushworth GF; Megson IL Pharmacol Ther; 2014 Feb; 141(2):150-9. PubMed ID: 24080471 [TBL] [Abstract][Full Text] [Related]
23. ENACT: a protocol for a randomised placebo-controlled trial investigating the efficacy and mechanisms of action of adjunctive N-acetylcysteine for first-episode psychosis. Cotton SM; Berk M; Watson A; Wood S; Allott K; Bartholomeusz CF; Bortolasci CC; Walder K; O'Donoghue B; Dean OM; Chanen A; Amminger GP; McGorry PD; Burnside A; Uren J; Ratheesh A; Dodd S Trials; 2019 Nov; 20(1):658. PubMed ID: 31779696 [TBL] [Abstract][Full Text] [Related]
24. The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. Raghu G; Berk M; Campochiaro PA; Jaeschke H; Marenzi G; Richeldi L; Wen FQ; Nicoletti F; Calverley PMA Curr Neuropharmacol; 2021; 19(8):1202-1224. PubMed ID: 33380301 [TBL] [Abstract][Full Text] [Related]
25. The Potential of N-Acetyl-L-Cysteine (NAC) in the Treatment of Psychiatric Disorders. Bradlow RCJ; Berk M; Kalivas PW; Back SE; Kanaan RA CNS Drugs; 2022 May; 36(5):451-482. PubMed ID: 35316513 [TBL] [Abstract][Full Text] [Related]
26. N-Acetylcysteine for Nonsuicidal Self-Injurious Behavior in Adolescents: An Open-Label Pilot Study. Cullen KR; Klimes-Dougan B; Westlund Schreiner M; Carstedt P; Marka N; Nelson K; Miller MJ; Reigstad K; Westervelt A; Gunlicks-Stoessel M; Eberly LE J Child Adolesc Psychopharmacol; 2018 Mar; 28(2):136-144. PubMed ID: 29053023 [TBL] [Abstract][Full Text] [Related]
27. The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial. Berk M; Dean OM; Cotton SM; Jeavons S; Tanious M; Kohlmann K; Hewitt K; Moss K; Allwang C; Schapkaitz I; Robbins J; Cobb H; Ng F; Dodd S; Bush AI; Malhi GS J Clin Psychiatry; 2014 Jun; 75(6):628-36. PubMed ID: 25004186 [TBL] [Abstract][Full Text] [Related]
28. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Mardikian PN; LaRowe SD; Hedden S; Kalivas PW; Malcolm RJ Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):389-94. PubMed ID: 17113207 [TBL] [Abstract][Full Text] [Related]
29. A minireview on N-acetylcysteine: An old drug with new approaches. Elbini Dhouib I; Jallouli M; Annabi A; Gharbi N; Elfazaa S; Lasram MM Life Sci; 2016 Apr; 151():359-363. PubMed ID: 26946308 [TBL] [Abstract][Full Text] [Related]
30. Nail-biting stuff? The effect of N-acetyl cysteine on nail-biting. Berk M; Jeavons S; Dean OM; Dodd S; Moss K; Gama CS; Malhi GS CNS Spectr; 2009 Jul; 14(7):357-60. PubMed ID: 19773711 [TBL] [Abstract][Full Text] [Related]
31. [Antioxidant treatment with N-acetylcysteine and vitamin C in patients with chronic bronchitis]. Lukas R; Schärling B; Schultze-Werninghaus G; Gillissen A Dtsch Med Wochenschr; 2005 Mar; 130(11):563-7. PubMed ID: 15761783 [TBL] [Abstract][Full Text] [Related]
33. N-acetylcysteine may prevent severe intestinal damage in necrotizing enterocolitis. Tayman C; Tonbul A; Kosus A; Hirfanoglu IM; Uysal S; Haltas H; Tatli MM; Andiran F J Pediatr Surg; 2012 Mar; 47(3):540-50. PubMed ID: 22424351 [TBL] [Abstract][Full Text] [Related]
34. N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial. Berk M; Copolov D; Dean O; Lu K; Jeavons S; Schapkaitz I; Anderson-Hunt M; Judd F; Katz F; Katz P; Ording-Jespersen S; Little J; Conus P; Cuenod M; Do KQ; Bush AI Biol Psychiatry; 2008 Sep; 64(5):361-8. PubMed ID: 18436195 [TBL] [Abstract][Full Text] [Related]
35. The role of depressive symptoms in treatment of adolescent cannabis use disorder with N-Acetylcysteine. Tomko RL; Gilmore AK; Gray KM Addict Behav; 2018 Oct; 85():26-30. PubMed ID: 29803870 [TBL] [Abstract][Full Text] [Related]
36. A review of N-acetylcysteine in the treatment of grooming disorders. Braun TL; Patel V; DeBord LC; Rosen T Int J Dermatol; 2019 Apr; 58(4):502-510. PubMed ID: 30667049 [TBL] [Abstract][Full Text] [Related]
37. Oxidative stress and therapeutic implications in psychiatric disorders. Zhang XY; Yao JK Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():197-9. PubMed ID: 23523744 [TBL] [Abstract][Full Text] [Related]